임상 시험 Nct 페이지
Clinical Trial Results:
A Phase IIa, multi-center, multi-national, open-label, dose ranging study of the efficacy, safety, and tolerability of oral DU-176b administered once or twice daily in the treatment of adult patients undergoing total hip arthroplasty.
| Summary | |
EudraCT number | 2004-004415-29 |
Trial protocol | GB LV |
Global completion date | 16 Dec 2005 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 26 May 2016 |
First version publication date | 26 May 2016 |
Other versions | |
Summary report(s) | Report Synopsis for DU176b-PRT007 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.